Facente Consulting collaborated with UCSF DeLIVER—a van-based, mobile hepatitis C test and treat model—to document and evaluate their implementation of a groundbreaking new hepatitis C testing technology in communities heavily impacted by hepatitis C.
Facente Consulting assisted a medical team at Stanford’s academic hospital with analyzing both qualitative and quantative survey data collected to explore the experiences and effects of gendered microaggressions by patients toward physicians.
Dr. Facente provided quality assurance and technical assistance to trainers in PEPFAR countries (Uganda and Cambodia) who were tasked with training their colleagues on the use of assays to detect recent HIV infections.
Facente Consulting produced the 2022 supplemental report for the 2020 Your Guide to Integrating HCV Services into Opioid Treatment Programs: Promising and Emerging Best Practices
Facente Consulting is supporting a second round of strategic planning for a growing Arizona-based HIV clinic.
Facente Consulting is supporting the County of San Diego Public Health Services in developing evaluation infrastructure for their HIV, STI, and Hepatitis Branch.
Facente Consulting supported the UCSF Pain and Addiction Research Center (PARC) in developing a strategic plan to maximize PARC’s impact.
To support workforce development among emerging behavioral health professionals, Facente Consulting developed an introductory-level overview guide about the intersection between behavioral health work and the syndemic of HIV, hepatitis C, sexually transmitted infections, and overdose.
Facente Consulting worked with the Desmond Tutu Health Foundation to strengthen PhD training capacity among faculty and trainees at two of South Africa’s eight designated Historically Disadvantaged Universities (HDUs).
Facente Consulting developed and delivered a two-hour lecture for clinical psychology students and others at Touro University who wanted to earn continuing education credits for learning about harm reduction.
Facente Consulting helped shape and execute an epidemiological analysis of patterns related to recency of HIV infection at the time of diagnosis in San Francisco, in relation to the COVID-19 pandemic.
Dr. Facente served as the project manager for the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) for more than a decade, providing high-level project coordination and analytic support to researchers focused on HIV incidence estimation around the world.
Dr. Tan at UCSF reached out to Facente Consulting for ongoing assistance with manuscript development, literature reviews, and technical editing to support grant submissions, helping to move her academic portfolio forward and support her overall research goals.
Facente Consulting worked with the Addiction Technology Training Center to (i) develop case studies of methadone programs that have successfully incorporated hepatitis C services into their model, and (ii) complete white papers on several related topics.
Facente Consulting helped develop a harm reduction infusion package to support support college professors in infusing harm reduction framework and methodology into course curricula.
Facente Consulting helped UCSF develop an equity framework for launching their new concept: a shared use mobile van designed to improve community-based research opportunities in San Francisco.
Even before COVID-19 made “Zoom” a household word, Facente Consulting worked with Hep C Free Allegheny to virtually facilitate a strategic planning process for their hepatitis C elimination initiative, cutting costs and maximizing efficiency while planning their next three years of priorities.
Facente Consulting conducted a needs assessment to help the Family Care Network at UCSF Benioff Children’s Hospital in Oakland, CA better understand how to meet the needs of women, infants, children, and youth living with HIV who use their services.
Facente Consulting, through a contract with the University of Missouri-Kansas City, provided multiple trainings to the members of the Overdose Response Network (ORN) to build the capacity and knowledge of its network of TA providers and technology transfer specialists, who respond to a variety of requests nationwide.
Facente Consulting supported the development of a guide to providing integrated HIV/HCV/STI testing, linkage and treatment in opioid treatment program settings.
Facente Consulting helped the Petersen HIV Clinics at the University of Arizona’s academic medical center create a first-ever strategic plan after a period of very rapid growth.
The DeLIVER team hired Facente Consulting to facilitate a series of meetings to help them strategize around staff turnover and sustainability, improve financial sustainability, create a community action board, and systematize volunteer engagement.
Facente Consulting developed a survey tool to measure statewide capacity of harm reduction interventions and delivering of a report on survey findings and recommendations.
Facente Consulting was hired by academic physicians at Stanford’s School of Medicine to coordinate the qualitative research aspects of a study designed to better understand gender-based differences in how academic physicians think about and experience success in their careers.
The Mid-America Addiction Technology Transfer Center hired Facente Consulting to design and implement a harm reduction consultation program to support organizations in Nebraska, Missouri, Kansas, and Iowa in implementing harm reduction work.
Facente Consulting was hired to develop a curriculum and virtual training for public defenders in Nevada on the state’s Good Samaritan Law.
Facente Consulting facilitated a workshop at the Pacific AIDS Education & Training Center’s annual conference, helping attendees learn concrete tips to better communicate the impact of their HIV programs.
Facente Consulting trained Hanoi Medical University Students in research synthesis methods.
In 2021, Facente Consulting was hired to take notes of a national meeting of U.S. experts exploring the potential of fluvoxamine as an early treatment for COVID-19, and turn the meeting outcomes into a peer-reviewed publication in a high-profile clinical journal.
Dr. Facente was a co-investigator on this two-year research study funded by the National Institute on Drug Abuse (NIDA), with the goal of better understanding the epidemiology of hepatitis C in three high-burden subpopulations in San Francisco.